Prota Therapeutics

Melbourne, Australia

Prota Therapeutics is a developer of new treatment for peanut allergy in children.

Jan 2024

Private Equity

Biotechnology Product Research Therapeutics

Top Investors

OneVenturesSPRIM Global Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prota Therapeutics

Who are Prota Therapeutics's investors?

Prota Therapeutics's investors include OneVentures, SPRIM Global Investments.

Where is Prota Therapeutics headquartered?

Prota Therapeutics is headquartered in Melbourne, Australia.

What does Prota Therapeutics do?

Prota Therapeutics is a developer of new treatment for peanut allergy in children.

What stage is Prota Therapeutics at?

Prota Therapeutics is at the Private Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 16, 2024.

MLA

"Prota Therapeutics — Funding & Investors." VCBacked, January 16, 2024, https://www.vcbacked.co/company/prota-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Prota Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/prota-therapeutics

Wikipedia (cite web)

{{cite web |title=Prota Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/prota-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 16, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.